SIRT1 and type 2 diabetes mellitus: Betanin treatment of rats with STZ-induced type 2 diabetes was associated with amelioration of insulin resistance and improved lipid profile, accompanied with modulation of the AMPK/SIRT1/NF-κB signalling pathway [56].